This approval is based on final data from the PRIMA trial, where the MyChoice CDx Test determined homologous recombination deficiency (HRD) status and was used to stratify advanced ovarian cancer ...

Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration. The diagnostic ...

Participants will be given a pathology request form and can have the blood test done at a convenient collection centre or at ...

A potential world-changing test developed in Queensland is set to be trialled among 1500 women in the hopes it can be come a ...

If you have recurrent or platinum-resistant ovarian cancer, your doctor may recommend folate receptor alpha (FRα) testing. If you test positive for elevated levels of FRα (expressed on 75 percent or ...

Only 23.3% of ovarian cancer patients receive BRCA testing, leading to higher treatment costs and advanced therapy lines. Non-White and low-income patients face increased financial toxicity, ...

In this video, Rebecca Stone, MD, MS, discussed the need for improved prevention and screening methods for ovarian cancer.

Add Yahoo as a preferred source to see more of our stories on Google. Ovarian cancer is usually diagnosed using a mix of scans and blood tests (Getty/iStock) A straightforward blood test shows promise ...

BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk works and why genetic testing and early screening matter.